Medical/Pharmaceuticals APAC News & Press Release Distribution

Medical/Pharmaceuticals

All
Global

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial

1. VISEN Pharmaceuticals has obtained the investigational new drug (IND) approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for the phase III China clinical trial (PaTHway China Trial) of TransCon PTH Solution for Injection (TransCon™ parathy...

2021-06-04 02:00 1903

Innovent and Lilly Jointly Announce the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with Gemcitabine and Platinum Chemotherapy as First-Line Therapy for People with Squamous Non-Small Cell Lung Cancer

SAN FRANCISCO and SUZHOU, China, June 3, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disease...

2021-06-03 17:09 4390

Peking University Biologics entering into Strategic Cooperation Agreement with Norwich Investment Limited

HONG KONG, June 3, 2021 /PRNewswire/ -- Peking University Biologics (hereinafter known as "PKU BIO") and Norwich Investment Limited (hereinafter known as "Norwich") announced today that both parties have entered into a Strategic Cooperation Agreement ("Agreement") to promote the business develop...

2021-06-03 16:29 2646

Peking University Biologics entering into Strategic Cooperation Agreement with Norwich Investment Limited

Grifols to provide Korean Red Cross with Procleix Panther for blood screening, extending donor testing leadership in Asia

- The 28 systems to be deployed across KRC's three laboratory sites will test about 94% of the country's blood donations - They will run the Procleix Ultrio Elite Assay, an advanced nucleic acid test (NAT) ensuring donation safety by detecting the potential presence of the most important infecti...

2021-06-03 11:00 2701

Clinical Trial Results of the BCMA CAR-T Co-developed by Innovent and IASO Biotherapeutics Commented in American Society of Hematology's Medical Journal "Blood"

SAN FRANCISCO, U.S. and SUZHOU, China, June 3, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major ...

2021-06-03 08:00 4417

First Patient Dosed in QBiotics & MSD Clinical Trial Collaboration for Unresectable Melanoma

* First patient dosed with QBiotics' lead oncology molecule tigilanol tiglate in combination with KEYTRUDA® (pembrolizumab) in a clinical trial collaboration with MSD (tradename of Merck & Co., Inc.,Kenilworth, NJ, USA) * The Phase Ib/IIa study will test the safety, optimal dose and tumour re...

2021-06-03 06:00 1820

Nanoform raises its mid-term business targets for 2025

HELSINKI, June 2, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced its raised mid-term business targets for 2025. The new targets are as follows: * To nanoform annually at least 70 new active pharmaceutical ...

2021-06-02 21:42 1412

Mindray Launches Resona I9 Ultrasound System, Revolutionizing General Imaging

SHENZHEN, China, June 2, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has announced the release of its latest general imaging diagnostic ultrasound system,Resona I9 , to it...

2021-06-02 19:04 6187

Mindray Launches Resona I9 Ultrasound System, Revolutionizing General Imaging

Betagenon AB announces investment and collaboration with Hong Kong-based MCG Technology Group Ltd

STOCKHOLM, June 2, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based biotech company focused on development of AMPK activator compounds, and MCG Technology Group Ltd, aHong Kong-based biotech investment group, today announced that MCG Technology Group will invest in and collaborate with Betagenon...

2021-06-02 16:23 1262

Therabody™ Announces Partnership With World-Renowned Footballer Cristiano Ronaldo

LOS ANGELES, June 2, 2021 /PRNewswire/ -- Therabody, the global leader in tech wellness and the creators of theTheragun®, announced today professional footballerCristiano Ronaldo as the company's newest Therabody Athlete. The partnership also marks the release of Therabody's largest global ad cam...

2021-06-02 15:00 1493

Therabody™ Announces Partnership With World-Renowned Footballer Cristiano Ronaldo

Antengene Announces Abstracts on Twelve Clinical Studies of Selinexor Selected by EHA 2021

SHANGHAI and HONG KONG, June 2, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...

2021-06-02 08:00 2692

Transcenta Announced Completion of First Patient Dosing in PET-CT Imaging Study of Radionuclide-Labeled CLDN18.2 Antibody

SUZHOU, China, June 2, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced completion of first patient dosing in PET-CT imaging st...

2021-06-02 08:00 1820

Antengene Announces Fifteen Clinical Studies and Results of Selinexor to be Presented at ASCO 2021

2021-06-02 08:00 2350

New 3M™ Harvest RC clarifier brings chromatography technology to harvest clarification with a single-stage solution for upstream processes

ST. PAUL, Minn., June 2, 2021 /PRNewswire/ -- 3M Health Care launched 3M™ Harvest RC clarifier, leveraging its proprietary fibrous chromatography media to deliver a single-stage purification solution for recombinant protein therapeutic manufacturing. It is the next generation in harvest and clar...

2021-06-02 01:00 5375

Puyi Biotechnology Completes Series B Financing

SHANGHAI, June 1, 2021 /PRNewswire/ -- Puyi (Shanghai) Biotechnology Co., Ltd. ("Puyi Biotechnology") recently announced the completion of its Series B financing led by Goldman Sachs Asset Management. The proceeds will be used to further augment R&D and business development. Puyi Biotechnology i...

2021-06-01 22:32 2298

BioVaxys And Bioproduction Partner Bio Elpida Begin Construction Of GMP Facility To Produce Clinical Supply For Planned Ovarian Cancer Vaccine Study

VANCOUVER, BC and LYON, France, June 1, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (US OTCQB: BVAXF)("BioVaxys" or "the Company") is pleased to announce that its bioproduction partner Bio Elpida of Lyon, France, has initiated construction of a new Good Manufacturing Prac...

2021-06-01 20:00 3729

Occlutech takes important step towards approval in China

SCHAFFHAUSEN, Switzerland, June 1, 2021 /PRNewswire/ -- Occlutech AG ("Occlutech" or the "Company") today announces that the planned recruitment of 180 patients has been reached in the Company's trial inChina for its ASD Occluder. The Occlutech ASD Occluder is used in the treatment of Atrial Sept...

2021-06-01 19:02 1654

Scripps Research Institute testing shows Viraleze highly active against UK COVID strain

MELBOURNE, Australia, June 1, 2021 /PRNewswire/ -- Australia's Viraleze anti-COVID nasal spray is active against the highly infectious UK variant of SARS-CoV-2, the virus that causes COVID-19, reducing infectivity of the virus by >98%, it was announced today in a major development for the product...

2021-06-01 17:30 1365

Scripps Research Institute testing shows Viraleze highly active against UK COVID strain

Australia's original prolonged-release melatonin now available over the counter at pharmacies

MAIN POINTS * Circadin® prolonged-release melatonin is now available without prescription1 * Circadin® is clinically proven in people aged 55 and over2 to help them fall asleep quicker, sleep better, wake refreshed, and in turn improve quality of life3 * Circadin® mimics the effect of the b...

2021-06-01 17:05 1110

Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis

Agreement Renews Successful Global Collaboration That led to Several Groundbreaking Therapies in Multiple Disease Areas KHK4083 Depletes OX40-Expressing T cells Associated with Atopic Dermatitis and Several Other Inflammatory Diseases Moderate-to-Severe Atopic Dermatitis Affects Nearly 30 Mill...

2021-06-01 16:00 4875

1 ... 238 239 240241242 243 244 ... 383